2 Beaten-Down Artificial Intelligence (AI) Stocks for Contrarian Investors to Consider Buying

▤ Summary

This article reviews two beaten-down AI-related stocks, Recursion Pharmaceuticals and Fiverr, as contrarian ideas for long-term investors. Recursion uses AI to speed drug discovery, but it still lacks approved products and must prove its platform can deliver clinical and regulatory success. Fiverr offers a freelance marketplace that has benefited from AI demand, but it now faces weaker revenue and declining active buyers. The piece argues that both stocks have upside if their strategies work, while also highlighting the significant risks tied to their current business trends.

▦ Linked Companies

Recursion Pharmaceuticals, Inc.

$50M to $100M